Traws Pharma Inc (TRAW) — Cash Flow-to-Debt Ratio
Traws Pharma Inc (TRAW) has a Cash Flow-to-Debt Ratio of -0.77x as of June 2026, meaning its operating cash flow of $-7.50 Million could theoretically repay -1% of its total liabilities ($9.78 Million) in one year. See Traws Pharma Inc (TRAW) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Traws Pharma Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Traws Pharma Inc across 15 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Traws Pharma Inc.
Annual Cash Flow-to-Debt Ratio for Traws Pharma Inc (2011–2025)
Year-by-year debt coverage analysis for Traws Pharma Inc. Check cash flow quality index of Traws Pharma Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.62x | $-18.18 Million | $11.25 Million | ▼ -207.2% |
| 2024 | -0.53x | $-29.79 Million | $56.59 Million | ▲ +64.7% |
| 2023 | -1.49x | $-17.93 Million | $12.01 Million | ▼ -1.4% |
| 2022 | -1.47x | $-16.29 Million | $11.06 Million | ▲ +29.3% |
| 2021 | -2.08x | $-19.49 Million | $9.36 Million | ▼ -24.6% |
| 2020 | -1.67x | $-23.07 Million | $13.81 Million | ▲ +3.0% |
| 2019 | -1.72x | $-20.83 Million | $12.10 Million | ▲ +4.9% |
| 2018 | -1.81x | $-22.70 Million | $12.54 Million | ▼ -20.4% |
| 2017 | -1.50x | $-23.82 Million | $15.84 Million | ▼ -72.2% |
| 2016 | -0.87x | $-15.81 Million | $18.11 Million | ▲ +64.8% |
| 2015 | -2.48x | $-31.31 Million | $12.61 Million | ▼ -2.2% |
| 2014 | -2.43x | $-57.65 Million | $23.71 Million | ▲ +4.0% |
| 2013 | -2.53x | $-61.38 Million | $24.25 Million | ▼ -37632.1% |
| 2012 | 0.01x | $1.63 Million | $242.16 Million | ▲ +106.8% |
| 2011 | -0.10x | $-14.17 Million | $142.88 Million | — |